Scientists propose CDK2 enzyme as new target for cancer therapy
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...
The EMBO Journal20h
LATS1/2 inactivation in the mammary epithelium drives the evolution of a tumor-associated niche
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...